Aurobindo Pharma Shares: Aurobindo Pharma shares fall as Sensex rises 404.02 points

The counter’s trading volume so far was 1:19 pm and sales were Rs 6.36. BSE.. The price-earnings ratio was a multiple of 7.39 and the price-to-book value ratio was 2.36.
A high price-earnings ratio indicates that investors are willing to pay a higher price for their earnings per rupee from their stocks, as expectations for future growth increase.
The price-to-book value ratio is a measure of the inherent value of a company and the price that an investor is ready to pay even if the business is not growing.
Aurobindo Pharma Ltd. belongs to the Pharma-Indian industry.
Promoter / FII Holding
The promoter held a 51.83% stake in the company as of September 30, 2021, while FII and domestic institutional investors owned 23.41% and 13.82%, respectively.
Major finances
The company reported consolidated net sales of Rs 6038.5 for the quarter ended September 30, 2021, an increase of 4.41% from Rs. 5783.29 in the previous quarter and an increase of 7.63% from Rs. 6537.19 in the same period last year.
Profit for the latest quarter was Rs 69.69 billion, down 13.55 percent from the year-ago quarter.
Aurobindo Pharma Shares: Aurobindo Pharma shares fall as Sensex rises 404.02 points
https://economictimes.indiatimes.com/markets/stocks/stock-watch/share-price-of-aurobindo-pharma-falls-as-sensex-gains-404-02-points/articleshow/87976822.cms Aurobindo Pharma Shares: Aurobindo Pharma shares fall as Sensex rises 404.02 points